Eledon Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview

Eledon Pharmaceuticals

10/08/2021 23:00

* Eledon Pharmaceuticals Inc  ELDN.OQ   ELDN.O  is expected
to show a no change in quarterly revenue when it reports
results on August 12. 
​* Refinitiv's mean analyst estimate for Eledon Pharmaceuticals
Inc is for a loss of 57 cents per share. For the same quarter
last year, the company reported a loss of $2.16 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $32​, about 80% above​ its last closing
price of $6.39. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.34       -0.32      -0.57     Missed  -78.1
 Dec. 31 2020  -0.31       -1.39      -2.12     Missed  -52
 Sep. 30 2020  -1.82       -1.75      -5.51     Missed  -215.5
                                                        ​
 Jun. 30 2020  -2.70       -2.97      -2.16     Beat    27.3
 Mar.          -2.86​      -2.88      -3.42     Missed  -18.7​
 31​ 2020​                                              
 Dec. 31 2019  -4.66       -4.68      -3.24     Beat    30.8​
 Sep. 30 2019  -7.38       -7.29      -3.96     Beat    45.7
 Jun. 30 2019  -7.65       -7.65      -6.30     Beat    17.6
 This summary was machine generated August 10 at 22:00 GMT.  All
figures in US dollars unless otherwise stated